Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars A Akslen

Showing results (11-20 of 228) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanomaOddbjørn Straume, David G Jackson, Lars A Akslen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancerOle J Halvorsen, Svein A Haukaas, Lars A Akslen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 25, 2009
Biologic markers in endometrial cancer treatmentIngeborg B Engelsen, Lars A Akslen, Helga B Salvesen
Cancer Research|March 17, 2006
Vascular proliferation is important for clinical progress of endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
Bioinformatics Advances|October 26, 2023
LOCATOR: feature extraction and spatial analysis of the cancer tissue microenvironment using mass cytometry imaging technologiesRezvan Ehsani, Inge Jonassen, Lars A Akslen, et al.
Oncotarget|December 7, 2017
Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomasMaria Ramnefjell, Christina Aamelfot, Lars Helgeland, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 25, 2017
Vascular invasion is an adverse prognostic factor in resected non-small-cell lung cancerMaria Ramnefjell, Christina Aamelfot, Lars Helgeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
International Journal of Cancer|September 10, 2005
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patientsIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
The Journal of Pathology. Clinical Research|September 19, 2018
Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapyCornelia Schuster, Lars A Akslen, Tomasz Stokowy, et al.
Pageof 23

Showing results (11-20 of 228) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanomaOddbjørn Straume, David G Jackson, Lars A Akslen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancerOle J Halvorsen, Svein A Haukaas, Lars A Akslen
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 25, 2009
Biologic markers in endometrial cancer treatmentIngeborg B Engelsen, Lars A Akslen, Helga B Salvesen
Cancer Research|March 17, 2006
Vascular proliferation is important for clinical progress of endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
Bioinformatics Advances|October 26, 2023
LOCATOR: feature extraction and spatial analysis of the cancer tissue microenvironment using mass cytometry imaging technologiesRezvan Ehsani, Inge Jonassen, Lars A Akslen, et al.
Oncotarget|December 7, 2017
Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomasMaria Ramnefjell, Christina Aamelfot, Lars Helgeland, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 25, 2017
Vascular invasion is an adverse prognostic factor in resected non-small-cell lung cancerMaria Ramnefjell, Christina Aamelfot, Lars Helgeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
International Journal of Cancer|September 10, 2005
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patientsIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
The Journal of Pathology. Clinical Research|September 19, 2018
Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapyCornelia Schuster, Lars A Akslen, Tomasz Stokowy, et al.
Pageof 23